Biotransformation of Ginsenoside Rb1 to Ginsenoside Rd by Highly Substrate-Tolerant Paecilomyces Bainier 229-7

Li Ye,Chao-Qun Zhou,Wei Zhou,Pei Zhou,Dao-Feng Chen,Xiao-Hui Liu,Xun-Long Shi,Mei-Qing Feng
DOI: https://doi.org/10.1016/j.biortech.2010.04.102
IF: 11.4
2010-01-01
Bioresource Technology
Abstract:Paecilomyces bainier 229-7 was obtained after UV irradiation for 8min in the presence of 0.4% LiCl and selection on potato dextrose media containing 30mg/mL saponin from Panax notoginseng leaves (SPNL). The mutant produces ginsenoside Rd from ginsenoside Rb1 with a bioconversion rate as high as 94.9% under optimized culture conditions in shake flasks when supplied with 20mg/mL of SPNL. Scale-up in 10-L fermenter resulted in an 89% bioconversion rate. Ginsenoside Rd was purified from the culture medium by a macroporous resin with a chromatographic purity of 92.6%. These results suggest that P. bainier 229-7 could be useful for the preparation of ginsenoside Rd in the pharmaceutical industry.
What problem does this paper attempt to address?